MADRIGAL PHARMACEUTICALS, INC.
MDGL
24 insider filings · Latest: Jun 17, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | Aug 29 8:06 PM | FRED CRAVES | Proposed Sale | 2,900 | $431.69 | $1.3M | — | View → |
| Aug 21, 2025 | Aug 21 8:24 PM | WILLIAM SIBOLD | Proposed Sale | 7,616 | $391.66 | $3.0M | — | View → |
| Aug 20, 2025 | Aug 20 8:12 PM | FRED CRAVES | Proposed Sale | 1,000 | $390.22 | $390.2K | — | View → |
| Aug 18, 2025 | Aug 18 9:30 PM | Shannon Kelley | Proposed Sale | 1,304 | $369.84 | $482.3K | — | View → |
| Aug 18, 2025 | Aug 18 8:23 PM | FRED CRAVES | Proposed Sale | 2,000 | $382.24 | $764.5K | — | View → |
| Aug 15, 2025 | Aug 15 9:34 PM | FRED CRAVES | Proposed Sale | 4,100 | $366.70 | $1.5M | — | View → |
| Aug 15, 2025 | Aug 15 8:42 PM | KENNETH M BATE | Proposed Sale | 10,000 | $365.20 | $3.7M | — | View → |
| Aug 13, 2025 | Aug 13 8:22 PM | PAUL FRIEDMAN | Proposed Sale | 129,172 | $359.00 | $46.4M | — | View → |
| Aug 12, 2025 | Aug 12 8:27 PM | REBECCA TAUB | Proposed Sale | 43,263 | $349.50 | $15.1M | — | View → |
| Aug 12, 2025 | Aug 12 8:26 PM | PAUL FRIEDMAN | Proposed Sale | 43,605 | $349.50 | $15.2M | — | View → |
| Aug 11, 2025 | Aug 11 8:26 PM | PAUL FRIEDMAN | Proposed Sale | 3,203 | $345.73 | $1.1M | — | View → |
| Aug 11, 2025 | Aug 11 8:26 PM | REBECCA TAUB | Proposed Sale | 3,200 | $345.73 | $1.1M | — | View → |
| Jul 18, 2025 | Jul 18 9:25 PM | PAUL FRIEDMAN | Proposed Sale | 1,400 | $348.73 | $488.2K | — | View → |
| Jul 18, 2025 | Jul 18 9:03 PM | REBECCA TAUB | Proposed Sale | 1,000 | $348.73 | $348.7K | — | View → |
| Jul 17, 2025 | Jul 17 8:21 PM | REBECCA TAUB | Proposed Sale | 2,657 | $344.97 | $916.6K | — | View → |
| Jul 17, 2025 | Jul 17 8:20 PM | PAUL FRIEDMAN | Proposed Sale | 2,700 | $344.97 | $931.4K | — | View → |
| Jul 16, 2025 | Jul 16 8:20 PM | PAUL FRIEDMAN | Proposed Sale | 26,176 | $311.14 | $8.1M | — | View → |
| Jul 16, 2025 | Jul 16 8:19 PM | REBECCA TAUB | Proposed Sale | 26,444 | $311.14 | $8.2M | — | View → |
| Mar 13, 2025 | Mar 13 9:03 PM | FRED CRAVES | Proposed Sale | 7,742 | $325.25 | $2.5M | — | View → |
| Mar 12, 2025 | Mar 13 5:26 PM | CRAVES FRED B | Proposed Sale | 7,728 | $331.85 | $2.6M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Jun 18 8:23 PM | Taub RebeccaDirector | Grant/Award | 766 | $499.86 | 766(D) | View → |
| Jun 17, 2026 | Jun 18 8:21 PM | Richard S LevyDirector | Grant/Award | 766 | $499.86 | 766(D) | View → |
| Jun 17, 2026 | Jun 18 8:19 PM | Jacqualyn A FouseDirector | Grant/Award | 766 | $499.86 | 766(D) | View → |
| Jun 17, 2026 | Jun 18 8:16 PM | James M DalyDirector | Grant/Award | 766 | $499.86 | 766(D) | View → |
| Jun 17, 2026 | Jun 18 8:12 PM | Daniel J. BrennanDirector | Grant/Award | 681 | $499.86 | 681(D) | View → |
| Jun 17, 2026 | Jun 18 8:03 PM | BAKER BROS. ADVISORS LPDirector | Grant/Award | 3,064 | $499.86 | 1,532(I) | View → |
| Mar 4, 2026 | Mar 7 12:18 AM | Mardi DierEVP and CFO | Grant/Award | 6,519 | $434.80 | 6,519(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | William John SiboldDirector, President and CEO | Grant/Award | 18,743 | $434.80 | 18,743(D) | View → |
| Mar 4, 2026 | Mar 6 11:34 PM | Shannon T KelleyGeneral Counsel | Grant/Award | 5,022 | $434.80 | 5,022(D) | View → |
| Mar 4, 2026 | Mar 6 11:15 PM | Carole HuntsmanChief Commercial Officer | Grant/Award | 4,986 | $434.80 | 4,986(D) | View → |
| Mar 4, 2026 | Mar 6 10:55 PM | David SoergelChief Medical Officer | Grant/Award | 5,467 | $434.80 | 5,467(D) | View → |
| Feb 23, 2026 | Feb 24 10:09 PM | Richard S LevyDirector | Option Exercise | 2,500 | $7.36 | 0(D) | View → |
| Jan 26, 2026 | Jan 26 11:02 PM | Richard S LevyDirector | Option Exercise | 4,000 | $16.46 | 0(D) | View → |
| Jan 15, 2026 | Jan 20 10:31 PM | Rita ThakkarChief Accounting Officer | Grant/Award | 1,826 | $495.88 | 1,826(D) | View → |